Brief: Actinium Pharmaceuticals Announces Pricing Of $16.5 Million Public Offering Of Common Stock And Warrants
April 18 (Reuters) - Actinium Pharmaceuticals Inc ATNM.A :
* ACTINIUM PHARMACEUTICALS, INC. ANNOUNCES PRICING OF $16.5
MILLION PUBLIC OFFERING OF COMMON STOCK AND WARRANTS
* ACTINIUM PHARMACEUTICALS INC - COMBINED PUBLIC OFFERING
PRICE OF
$0.385 PER SHARE OF COMMON STOCK.
Source text for Eikon: ID:nPn1Q7lfga
Further company coverage: ATNM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actinium Pharmaceuticals
See all newsBrief: Actinium Pharmaceuticals - Receives Two Canadian Patent Allowances For Actimab-A And Iomab-Act Programs
Brief: ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCS
Brief: Actinium Pharmaceuticals Says ATNM-400 Shows Superior Efficacy To Xtandi In Prostate Cancer
Brief: Actinium Pharmaceuticals Announces ATNM-400 A Novel Non-PSMA Targeting First In Class Prostate Cancer Radiotherapy Leveraging Actinium-225
Brief: Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities